Controversy about breast cancer in situ

Authors

  • Gildardo Gallego Noreña

DOI:

https://doi.org/10.18597/rcog.677

Keywords:

Lobulillar and ductal cancer in situ, conservative treatment for breast cancer

Abstract

This article presents the principal aspects of in situ breast cancer; it describes concepts about lobulillar and ductal in situ breast cancer.

The lobulillar cancer is only a marker of future breast cancer. The ductal cancer in situ is a predictor of invasive cancer in the future. The participation of a patient to take decisions about her treatment is very important. Each case would be seen in an independent way and today there is a tendency to conservative treatment and no radical surgeries. There are precise indications to perform mastectomy or conservative treatments as cuadrantectomy or local resections.

It emphasizes the importance of free margin when we perform conservative manner, thus guarantee the success of treatment. The recurrence percentage is the same when we use conservative or radical treatment.

Author Biography

Gildardo Gallego Noreña

Profesor Emérito. Universidad de Antioquia.

References

Fisher Edwin. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast, Ca cancer J Clin 1996; 47: 52-64.

McNelis John, MD, Wise L. Carcinoma in situ, Clin Obst y Gin de Norte América 1994; 2: 917-920.

Guías de manejo de tumores mamarios. Revista Colombiana de Obstetricia y Ginecología 1998; 48(4).

González J Merlo y cols.: Oncología Ginecológica, Salvat Editores, Mallorca, Barcelona, 1991; 379-542.

Alvarez GE, Tejerina Gómez A. Mastología Dinámica, Díaz de Santos S.A. Madrid, 1995.

Hetelekidis S, Schnitt S. Morrow M, Harris J. Managements of ductal carcinoma in situ Ca Cancer J Clin 1995; 45: 244-253.

Hughes KS, Lee AK, Rolfs A. Controrversies in the treatment of ductal carcinoma in situ. Surgical Clinics of North America. 1996; 76(2): 243-265.

Marchant DJ. Breast Disease. W.B. Saunders Company, Philadelphia Pennsylvania: 1997; 163-195-213.

López MI. Conceptos actuales en el manejo del cáncer mamario. Trib Med 1992; 85: 117-133.

Petrek I. Cáncer mamario, Clin Obst y Ginec 1994; (4): 885-896.

Hortobagyi GN, Buzdar AV. Current status of adjuvant systemic therapy for primary breast cancer: Progress and controversy. CA Cancer J Clin 1995; 45: 199-226.

Gutiérrez R. Cáncer del seno: su tratamiento quirúrgico primario, Rev Col de Cirugía 1993; 8(1): 37-44.

Torres Trujillo R. Tumores de Mama. primera edición, México, Interamericana, Mcgraw Hill, 1994.

Maldonado H. Tratamiento conservador del cáncer mamario. Rev Col de Cirugía. 1993; 8(1): 30-36.

Perry F. Rev Colomb Obstet Ginecol 1995; 46(1): 11-15.

How to Cite

1.
Gallego Noreña G. Controversy about breast cancer in situ. Rev. colomb. obstet. ginecol. [Internet]. 2000 Sep. 29 [cited 2024 May 17];51(3):169-72. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/677

Downloads

Download data is not yet available.

Published

2000-09-29
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo